Status:
RECRUITING
Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity
Lead Sponsor:
General University Hospital, Prague
Conditions:
Molecular Markers of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity
Eligibility:
FEMALE
18-45 years
Brief Summary
The primary aim of the project is to analyse gene expression in individual types of ectopic endometrium (ovarian endometriosis, peritoneal endometriosis, deep infiltrating endometriosis) and compare i...
Detailed Description
Endometriosis is defined as the presence of endometrial-like tissue outside the uterine cavity. It is a chronic benign estrogen-dependent disease affecting approximately 10% of women of reproductive a...
Eligibility Criteria
Inclusion
- women (18-45 years)
- signed informed consent with the study
- absence of hormonal treatment 3 months before the planned procedure
- Inclusion criteria for group A:
- \- laparoscopically and histologically confirmed endometriosis dg.
- Inclusion criteria for group B:
- patients without endometriosis
- patients who are undergoing an elective laparoscopic or hysteroscopic procedure in our department for another benign indication
- patients with excluded malignant disease
Exclusion
- absence of informed consent
- patients who do not meet the inclusion criteria during surgery
- patient younger than 18 years of age or older than 45 years of age
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06020482
Start Date
April 1 2023
End Date
December 31 2026
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General University Hospital in Prague
Prague, Czechia, 12808